Changsheng Ye

1.2k total citations
58 papers, 813 citations indexed

About

Changsheng Ye is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Changsheng Ye has authored 58 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cancer Research, 19 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Changsheng Ye's work include Cancer-related molecular mechanisms research (8 papers), Land Use and Ecosystem Services (6 papers) and Breast Cancer Treatment Studies (6 papers). Changsheng Ye is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), Land Use and Ecosystem Services (6 papers) and Breast Cancer Treatment Studies (6 papers). Changsheng Ye collaborates with scholars based in China and United States. Changsheng Ye's co-authors include Guangyu Yao, Jianyu Dong, Xiaolei Hu, Minfeng Liu, Lujia Chen, Zhaoze Guo, Qiang Shen, Xiaojing Meng, Zhengduo Yang and Fei Zou and has published in prestigious journals such as International Journal of Molecular Sciences, Cancer Letters and Sustainability.

In The Last Decade

Changsheng Ye

55 papers receiving 803 citations

Peers

Countries citing papers authored by Changsheng Ye

Since Specialization

Citations

This map shows the geographic impact of Changsheng Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changsheng Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changsheng Ye more than expected).

Fields of papers citing papers by Changsheng Ye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changsheng Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changsheng Ye. The network helps show where Changsheng Ye may publish in the future.

Co-authorship network of co-authors of Changsheng Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Changsheng Ye. A scholar is included among the top collaborators of Changsheng Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changsheng Ye. Changsheng Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efbemalenograstim Alfa, an Fc Fusion Protein, Long‑Acting Granulocyte Colony-Stimulating Factor for Reducing the Risk of Chemotherapy-Induced Neutropenia: Results of a Phase II Randomized, Multicenter, Open‑Label Trial 2025 ·Clinical Drug Investigation ·Dongmei Ji, Shufang Wang, (unknown), Dibo Hou, Xiaoyan Wang, Changsheng Ye, Hongsheng Li, Hongjian Yang, (unknown), Jingjing Lu, Haibo Wang, (unknown), Dongyan Cai, Xiaoan Liu, Xi Yan, Jianyun Nie, (unknown), (unknown), Junning Cao	0
2	Research on the impact of county urbanization in Jiangxi Province on carbon budget balance 2025 ·Environmental Monitoring and Assessment ·Yuhang Li, Changsheng Ye, (unknown)	1
3	A randomized, multicenter phase III Study of once-per-cycle administration of efbemalenograstim alfa (F-627), a novel long-acting rhG-CSF, for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer 2024 ·BMC Cancer ·Qingyuan Zhang, Zhonghua Wang, (unknown), (unknown), (unknown), (unknown), (unknown), Simon Li, Hongsheng Li, Changsheng Ye, Tao Sun, Hongjian Yang, Zhendong Chen, Zhihong Wang, Xiaoan Liu, Cuizhi Geng, Xingrui Li, Jin Zhang, Hong Zheng, Zhimin Shao	3
4	Responses of magnetic properties to heavy metals pollution recorded by sediments of Nanchang City reach of Ganjiang River, East China 2024 ·Environmental Geochemistry and Health ·(unknown), Wen Li, Changsheng Ye, Yuan Gao, Yuqin Zhou	1
5	Analysis of urban carbon metabolism from the land use perspective: a case study of Nanchang, China 2024 ·Urban Ecosystems ·(unknown), Changsheng Ye	1
6	Slowing the expansion of impervious surfaces: the key to promoting high-quality and sustainable regional development 2024 ·Environmental Science and Pollution Research ·(unknown), Changsheng Ye, (unknown), (unknown), (unknown), Qian Dong	3
7	Aeolian activities change and possible mechanisms in central Asia on sub-orbital to decadal timescales 2023 ·Quaternary International ·(unknown), Changsheng Ye, (unknown), Gen Li	4
8	Aeolian activity in the southern Gurbantunggut Desert of China during the last 900 years 2023 ·Journal of Arid Land ·Wen Li, Guijin Mu, Changsheng Ye, Lishuai Xu, Gen Li	3
9	Sauchinone inhibits breast cancer cell proliferation through regulating microRNA‐148a‐3p/HER‐2 axis 2023 ·Thoracic Cancer ·(unknown), Jie Wang, Pei Shang, Shan Wang, Lujia Chen, Changsheng Ye, Guangyu Yao	5
10	Host-guest complexation of cyclophosphamide by carboxylatopillar[6]arene for increasing stability and enhancing its curative effect on breast carcinoma 2022 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Lingxiao Pan, Xiaoshen Zhang, Changsheng Ye, Junyi Chen, Chunju Li	2
11	Prevalence of breast fibroadenoma in healthy physical examination population in Guangdong province of China: a cross-sectional study 2022 ·BMJ Open ·Lijun Zhu, (unknown), Shanshan Jiang, Si‐Min Ruan, Huanrong Ma, Yingjia Li, Changsheng Ye, Jianyu Dong	7
12	Cardiovascular risk factors and breast cancer incidence in a large middle-aged cohort study 2022 ·BMC Cancer ·(unknown), Shanshan Jiang, Si‐Min Ruan, Lijun Zhu, (unknown), Minfeng Liu, Zhaoze Guo, Jingyun Guo, Changsheng Ye, Yun‐Jiu Cheng, Jianyu Dong	7
13	NIR Photosensitizer for Two-Photon Fluorescent Imaging and Photodynamic Therapy of Tumor 2021 ·Frontiers in Chemistry ·(unknown), (unknown), Yuping Zhou, Changsheng Ye, Ruiyuan Liu	17
14	Assessment of circulating HISLA as a potential biomarker for breast cancer diagnosis and prognosis 2020 ·Clinical and Experimental Medicine ·(unknown), Jintao Hu, Yipeng Yang, Wenbin Zhou, Changsheng Ye	10
15	Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer 2020 ·Journal of Translational Medicine ·Jing Chen, Changsheng Ye, Jianyu Dong, Shunwang Cao, Yan‐Wei Hu, Bo Situ, (unknown), Sihua Qin, Jiasen Xu, Zhen Cai, Lei Zheng, Qian Wang	37
16	Short-duration versus 1-year adjuvant trastuzumab in early HER2 positive breast cancer: A meta-analysis of randomized controlled trials 2019 ·Cancer Treatment Reviews ·Lujia Chen, (unknown), Xiaolei Hu, (unknown), Changsheng Ye, Guangyu Yao	32
17	Invasive micropapillary carcinoma of the breast had poor clinical characteristics but showed no difference in prognosis compared with invasive ductal carcinoma 2016 ·World Journal of Surgical Oncology ·(unknown), (unknown), Jia Yao, Zhenping Wang, Guangyu Yao, Mingfeng Liu, Changsheng Ye	18
18	TRPM7 mediates breast cancer cell migration and invasion through the MAPK pathway 2013 ·Cancer Letters ·Xiaojing Meng, Chunqing Cai, (unknown), Shaoxi Cai, Changsheng Ye, (unknown), Zhengduo Yang, (unknown), Qiang Shen, Fei Zou	123
19	MT1-MMP in breast cancer: induction of VEGF-C correlates with metastasis and poor prognosis 2013 ·Cancer Cell International ·Guangyu Yao, Pingnian He, Lujia Chen, Xiaolei Hu, (unknown), Changsheng Ye	21
20	Evaluation on angiogenesis of benign and malignant breast tumors with contrast enhanced microvascular imaging 2009 ·Changsheng Ye	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact